Skip to content

Revvity

$RVTYHealthcare Save RVTY

XNYS · Diagnostics & Research

Last stored close · Nov 10, 2026

Close · Nov 10, 2026

$159.10-1.01%

The live price is free with an account

Model Target

available with Pro

Implied upside

vs the model target

Valuation methods

the methods behind the target

43/100

Weak

QUALITY26VALUE20TECH79RISK51SENT55
Quality & growth26
Valuation20
Technical79
Risk51
Sentiment Signal55

weighted blend of the five model families · nightly cross-sectional scoring · the Sentiment Signal breathes intraday

Revvity scores 43 out of 100 overall, which we rate weak. Technical is its strongest area and Valuation its weakest.

Computed summary · a narrated read appears after the next narration pass

What helps

  • Technical
  • Risk
  • Sentiment Signal

What to watch

  • Quality & growth
  • Valuation

AI narration of the model output · research, not investment advice · Nov 10, 2026, 21:47 UTC

Price history

RVTY · 260 stored daily closes · Oct 29, 2025 – Nov 10, 2026+66.9% over the series
$80.00$100.00$120.00$140.00$160.00Oct 29, 2025Mar 5, 2026Jul 10, 2026Nov 10, 2026

Intraday to five-year windows are free with an account

Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.

Market intelligence

Peer position

Healthcare

#117 / 139sector rank by TickerWhale Score

TickerWhale Score 43 vs sector average 54.6 (-11.6)

Revenue growth (industry)Top 89%

Gross margin (industry)Top 41%

Return on equity (industry)Top 71%

P/E (industry)Pricier than 86%

Compare with peers →

Technical analysis

our read · what classic indicators say

79/100Strong vs universe

Ranks 79th of 100 covered names on our technical composite — the composite itself scores 74/100 · 25% of the TickerWhale Score

Buy

3 buy · 1 sell · 4 neutral of 8 votes

Textbook signals on this stock alone — not part of the TickerWhale Score

TickerWhale rates RVTY's technical setup strong — 79th percentile of the covered universe. Classic chart indicators lean buy, pointing the same way.

8 / 9constructive

  • vs 200-day+40.4%
  • vs 50-day+6.9%

Mixed

  • RSI (14)54 · neutral
  • Stochasticbuy
  • CCIneutral
  • Williams %Rneutral

Mixed

  • ADX (14) trend strength20· weak trend
  • MACD (12,26,9)sell(histogram -0.856)

8 votes · 9 moving averages count as one · Bollinger %B never votes

Strong Sell
Sell
Neutral
▲ Buy
Strong Buy

Moving averages (9) agree on buy — 8 buy vs 0 sell — and carry one vote between them.

Oscillators (7) vote individually: 2 buy · 1 sell · 4 neutral.

Result — 3 buy vs 1 sell of 8 votes = Buy. Neutral votes never decide the verdict.

Across all 17 tracked indicators: 10 buy · 6 neutral · 1 sell — a different count from the 8 votes above, because the 9 averages are counted individually here · true range basis · data as of Nov 10, 2026

Fundamentals & valuation

2026-11-10 · revised_latest
  • P/E (TTM)74.8
  • P/S (TTM)6.1
  • P/B2.5
  • EV/EBITDA—
  • EV/Sales6.8
  • PEG—
  • Gross margin55.0%
  • Net margin8.2%
  • ROE3.3%
  • Debt/Equity0.44
  • Revenue growth (YoY)4.0%
  • EPS growth (YoY)-11.0%

Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.

Market capitalisation — $17.8B

Fundamentals history

Reported statement totals across recent periods.

No annual statement history is available for this security yet.

Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.

Model Target

Model Target is a Pro feature

Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.

The Model Target is a TickerWhale Pro feature

A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.

Or see the current free one: KNSA →

Peers

CompanyScorePulseP/EP/E fwdP/BEV/SalesPriceChgEstimateUpsideRev. gr.
RVTYCurrentRevvity437474.8—2.56.8$159.10-1.01%+4.0%
EXELExelixis828821.3—9.97.4$70.58-1.62%+9.2%
KNSAKiniksa Pharmaceuticals International plc. -798198.2—12.19.3$95.02-3.79%+58.9%
THCTenet Healthcare798110.9—5.21.6$290.27+0.44%+7.5%
INCYIncyte766715.5—3.93.6$120.30-1.30%+26.9%
LIVNLivaNova768427.2—3.93.3$91.14-1.59%+12.4%

News, sentiment, the Street view and Ask Willy are free with an account

A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.